Updated:
Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation is a medical device company. It developed the Dbx Demineralized Bone Matrix Putty. The firm has made three investments,...
Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation is a medical device company. It developed the Dbx Demineralized Bone Matrix Putty. The firm has made three investments, including a seed investment in AmnioChor on July 29, 2015.
General information
Firm type
Foundation
Year founded
1987
Location
Region
North America
Country
United States
City
Edison
Corporate office
Edison, NJ, United States
Principals
Joe Yaccarino
President & CEO
Dr. Matthew F. Myerson
Chief Medical Officer
Sector focus
Frequently asked questions
Who runs investment decisions at MTF?
MTF is a nonprofit tissue bank, not an investment firm. Operational revenue is managed by the CFO and a board of directors — there is no separate investment office. Surplus funds are placed in conservative instruments per nonprofit best practices.
How does MTF source proprietary tissue supply?
MTF relies on an extensive network of nearly 70 donor-recovery centers across the US and relationships with tissue recovery agencies. Tissue donation is voluntary and regulated by FDA and state laws.
Is MTF structured as a single family office or an asset manager?
Neither. MTF is a 501(c)(3) nonprofit foundation that operates the world's largest tissue bank. It is not an investment vehicle or family office. Its financial model is donation-sourced tissue, processed and sold to healthcare providers.
Does MTF participate in fund commitments or only direct operations?
MTF does not participate in alternative investment funds. Its capital is deployed solely into its own operational infrastructure — recovery, sterilization, distribution, and R&D. There is no external investment strategy.
Which sectors does MTF explicitly focus on?
MTF is exclusively focused on musculoskeletal tissue transplantation and advanced wound care. It does not invest in or grant to unrelated sectors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: